# Advisor Review - Advisor 1/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-24T10:34:11.935927
**Response ID:** resp_0a5ca3ac62f49d39006974917242788192834a1512c391742f
**Tokens:** 7933 in / 3708 out
**Response SHA256:** f3a800a248c1e7d3

---

## 1) DATA–DESIGN ALIGNMENT (CRITICAL)

### a) Treatment timing vs. data coverage
- Data window used for estimation: **2012, 2014, 2016, 2018, 2020** (biennial).
- Latest **estimated treatment cohort** in Table 1: **2020** (ID, NV, OR, WA).
- Latest data year: **2020**.

No impossibility of the form “treated after data ends.” (CT/CO/WI are correctly treated as **not-yet-treated through 2020** and used as controls, not as treated cohorts.)

### b) Post-treatment observations for each cohort
From Table 1:
- 2014 cohort (ME): post periods = 4 (2014–2020)
- 2016 cohort (VT): post periods = 3 (2016–2020)
- 2018 cohort (AZ/MI/NM): post periods = 2 (2018–2020)
- 2020 cohort (ID/NV/OR/WA): post periods = 1 (2020)

Each estimated treated cohort has at least one post-treatment observation.

### c) Treatment definition consistency
- The paper consistently distinguishes **legislative authorization year** vs. **estimation cohort (first observable post period)** (e.g., ID/NV authorized 2019 → cohort 2020).
- Minnesota is consistently handled as **always-treated** and excluded from estimation (Table 1 notes + Section 4.3 + Section 3.3).

No internal contradictions that would break the DiD design mechanically.

## 2) REGRESSION SANITY (CRITICAL)

Checked reported numerical results (Table 3 and event-study summary numbers):
- Table 3 ATT magnitudes are plausible for a proportion outcome (−0.013, −0.011).
- Standard errors are plausible (0.006) and not orders of magnitude larger than coefficients.
- No “NA/NaN/Inf,” negative SEs, or impossible intervals.

No regression-output red flags that indicate a broken specification/output.

## 3) COMPLETENESS (CRITICAL)

- Tables referenced (Table 1–3) appear present with required numerical entries.
- Figures referenced (Figure 1–3) appear to exist (as shown in the provided pages).
- Sample size for the main estimate is reported in Table 3 notes (**N = 245 state-years**), and treated/control counts are provided (Tables 2–3 notes).

No placeholders like TBD/TODO/XXX/NA in results tables, and no described-but-missing core results.

## 4) INTERNAL CONSISTENCY (CRITICAL)

- Abstract main estimate (−1.3 pp; SE = 0.6 pp; p = 0.041) matches Table 3 primary spec (ATT = −0.013; SE = 0.006; p = 0.041).
- Pre-trends statement (p = 0.12) is consistent with the reported χ² test in Section 5.2.
- State counts are coherent: 49-state sample excluding Minnesota; treated states = 9; comparison = 40; total state-period observations = 49×5 = 245.

No hard numerical contradictions across text/tables/figures.

ADVISOR VERDICT: PASS